hLIF-O5 is an inhibitor of LIF activation. OV cells still had higher clonogenicity compared to +/+ cells when cultured with hLIF-05 ( Figure S2D ). Conditioned media (CM) from cancerous cells having higher JAK-STAT3 activity can support cell growth (Yoon et al., 2012) . Similarly we found that +/À ESCs cultured at clonal density in CM from OV cells showed rescue of the Asrij-depletion phenotype and improved clonogenicity ( Figure S2E ). SOCS3 is a direct target of JAK-STAT pathway inflicting a negative feedback loop (Ying et al., 2003) . We found increased socs3 expression in OV cells and vice-versa in +/À cells ( Figure S2F ) indicating a direct effect from LIF-JAK-STAT3 pathway. The ability of Asrij to maintain pluripotency even in defined media (N2B27) without LIF supports the model that Asrij modulates pSTAT3 levels downstream of LIF-gp130 activation. We also observed increased expression of gp130 receptor itself in OV cells indicating a positive feedback from LIF-STAT3 pathway (Figures S2G and S2H) .
We found STAT3 phosphorylation levels to be directly proportional to Asrij levels (Figures 2F and 2G) . To test whether Asrij acts downstream of STAT3 phosphorylation, we treated cells with a potent STAT3 inhibitor JSI124 (Blaskovich et al., 2003) that blocks STAT3 phosphorylation. Based on reports in the literature, we treated cells with 20 mM or 40 mM JSI124 and compared them to untreated cells. Both +/+ and OV cells looked more differentiated in media with 40 mM JSI124 ( Figure S3A ). Further the maximum reduction in STAT3 phosphorylation was seen at 40 mM conditions in both +/+ cells and OV cells ( Figure S3B ). This was accompanied by a significant reduction in growth rate in the presence ( Figure S3C ) or absence ( Figure S3D ) of LIF and reduced clonogenicity in the presence of LIF ( Figure S3E ). Both +/+ and OV cells also showed reduced expression of pluripotency markers compared to untreated cells ( Figure S3F ). Upon passaging at clonal density in the presence of JSI124 OV cells behaved like +/+ and could not maintain self-renewal ( Figure S3G ), unlike untreated cells. Thus Asrij overexpression cannot overcome the effect of STAT3 inhibition indicating that functional STAT3 is required to carry out Asrij mediated stem cell maintenance in ESCs. These data are in concordance with the results in Drosophila where STAT92E knockdown induces differentiation in lymph gland ( Figure 3D ).
LPA (lysophosphatidic acid)-treated ovarian carcinoma cells upregulate asrij and show increased secondary colony formation (Sengupta et al., 2008) . Similarly LPA treatment resulted in improved clonogenicity of +/+ and +/À mESCs ( Figure S2I ) along with increased asrij, oct3/4 and c-myc expression ( Figures S2J and S2K ). OV cells also expressed higher lpar1 and lpar3 receptor transcripts ( Figure S2L ).
EXTENDED EXPERIMENTAL PROCEDURES
Gene-trapped ESC clones for asrij were purchased from the German Gene Trap Consortium and analyzed for insertion site by genomic DNA PCR and for expression by RT-PCR. P014G06 has an insertion at the end of intron2, 5 bp upstream of the translation start codon. It shows reduced Asrij expression (Figures 1A and 1B) and hence was used as +/À stock. For generation of an Asrij-overexpressing ES cell line, Asrij ORF (aa 1-247) cloned into pCMVNeo was transfected into R1 ES cells using lipofectamine, neomycinresistant colonies selected and checked for genomic integration by PCR and Asrij overexpression by RT-PCR and Western blot analysis (see Table S1 for primers). Four overexpressing clones were confirmed by preliminary phenotypic analysis and one designated OV was selected for further study.
To generate ESC lines stably expressing Asrij N terminal or C-terminal part, pCDNA3.1 vector containing arjN (aa 1-132) or arjC (aa 132-247) fragments were transfected in R1 ES cells by standard methods. Stable ESC clones were selected after neomycin treatment and checked for transgene integration by genomic DNA PCR ( Figure S3Hi ) and expression of Asrij fragments by . Primers used for validation are listed in Table S1 . Genomic DNA amplification showed expected bands of 333bp in arjN but not arjC cells and 408 bp in arjC but not arjN cells. Expression vector expressing full length Asrij was used as a positive (+) control. RTqPCR analysis of expression of arjN and arjC fragments from stable ESC lines was compared to expression from wild-type +/+ ESCs (dotted line in Figure S3Hii ).
pCMV-hLIF05 construct (kind gift from Ian Chambers, Edinburgh) was transfected into COS7 cells to obtain hLIF05 containing-media and tested for activity at various dilutions with or without 100u/ml LIF for clonogenicity assay as described before (Chambers et al., 2003) . Briefly, 300 wild-type ESCs were plated on each well of a gelatinized 24 well dish in mESC media with or without 1/ 10 th of LIF (i.e., 100U/ml). hLIF-05 was added at dilutions of 1:2, 1:4, 1:6, 1:8 to the ES media and cells were further grown for 4 days. 1:2 and 1:4 dilution showed substantial reduction in wild-type colony formation even in the presence of LIF. These concentrations were used for OV cells as well to check their clonogenic capacity.
qRT-PCR analysis was on 2 mg total RNA extracted from 48 hr feeder-free ES cell cultures by TRIzol reagent (Invitrogen Corp, USA) following the manufacturer's recommendations and reverse transcribed using Superscript II. cDNA was analyzed by PCR with specific primers (Table S1 ). qPCR was carried out using Evagreen (Bio-RAD) in a Biorad-CFX 96 Thermal Cycler. Average fold changes from three independent experiments were plotted with standard deviation. Primers used are given in Table S1 .
For Western Blot analysis cells were pelleted, washed with PBS, lysed in lysis buffer containing 25 mM HEPES, 150 mM NaCl, 1% NP-40, 10% glycerol, 10 mM MgCl 2 , 1 mM EDTA, protease inhibitor cocktail, phosphatase inhibitor 2 and phosphatase inhibitor 3 cocktail (Sigma) overnight at 4 C, clarified by centrifugation and 20 mg of lysate loaded on a 12% SDS-PAGE gel and electroblotted onto Nylon membrane. The blot was probed with appropriate primary antibody overnight at 4 C, washed, then probed with appropriate HRP conjugated secondary antibodies (Bangalore Genei, Bangalore) for 1 hr at RT and developed using ECL chemiluminescence kit (Thermo Scientific). Primary antibodies were against STAT3, Y 705 STAT3, ERK, Phospho-ERK 1,2 (Cell Signaling Technology, USA), Asrij (Mukhopadhyay et al., 2003) , GAPDH and FLAG (SIGMA Chemical Co., USA).
Mouse experiments were carried out in accordance with the guidelines of CPCSEA (Committee for the purpose of control and supervision of experiments on animals). NOD-SCID mice were subcutaneously injected with 10 7 cells (PBS for control), teratoma were harvested after 45 days, frozen, processed for cryosectioning (10mm) and RNA isolation (as mentioned previously). Sections were stained with Haemotoxylin and Eosin.
For JAK1i (Calbiochem, USA), JSI-124 (Cucurbitacin 1; Calbiochem, USA) and LY294002 (SIGMA, Chemical Co., USA) inhibitor experiments, cells were serum starved for 12 hr, induced with LIF in serum free medium either with or without the inhibitors (JAK1i at 10 nM, Cucurbitacin at 20 and 40 mM and LY294002 at 50 mM concentration) and cultured for another hour and then taken for Western Blot analysis. For long term experiments, ES cells were cultured in the presence of cucurbitacin 1 and media was changed everyday. Cells were cultured in 1 mM PD0325901 or 20 mM LPA (SIGMA, Chemical Co., USA) at clonal density for 4-5 days and then taken for clonal assay. LPA treated +/+ and +/À cells were taken for RNA extraction and RT-qPCR analysis also.
For subcellular fractionation, 10 7 cells were pelleted, lysed in lysis buffer, nuclei pelleted at 720 g and supernatant later spun at 100,000 g to obtain membrane pellet and cytosol supernatant. These fractions were validated by doing Western Blot analysis for fractionation markers such as GAPDH (Sigma Chemical Co. USA) for cytosolic fraction (CF), E-Cadherin (BD) for membrane fraction (MF) and STAT3 (CST, USA) for nuclear fraction (NF). For flow cytometry analysis 50,000 cells on gelatinized 60 mm dish were pelleted after 48 hr, washed in PBS, blocked in 5% FBS and stained in the same solution with antibodies to Asrij, OCT3/4 (BD) and gp130 (R&D, USA) for 1 hr. Excess antibodies were washed off in 5% FBS solution and stained with appropriate Alexa conjugated secondary antibodies and analyzed by flow cytometry.
For conditioned media (CM) experiments, +/+ and +/À cells were seeded at clonal density on gelatinized dishes and fed with CM collected from +/+ and OV cells cultured at normal density in mESC medium without serum and LIF. After 4-5 days cells were scored for clonogenicity by alkaline phosphatase staining.
Fly stocks were maintained at standard conditions (25 C). Canton(S) was used as the wild-type and w1118 or the respective UAS or Gal4 parent lines as controls where required. For expression in transgenic flies, Drosophila asrij full length cDNA (BDGP clone ID AT12418) or N terminal (aa 1-132) or C-terminal (aa 133-257) fragments or mouse asrij full length cDNA (Mukhopadhyay et al., 2003) were cloned into pUAST vector and transgenic flies generated by standard procedures. Other stocks used in this study were arj 9 /arj 9 , Figure S1 . Asrij Expression Analysis, Related to Figure 1 
